90 related articles for article (PubMed ID: 30675277)
1. Genomic amplification of HPV, h-TERC and c-MYC in liquid-based cytological specimens for screening of cervical intraepithelial neoplasia and cancer.
Ji W; Lou W; Hong Z; Qiu L; Di W
Oncol Lett; 2019 Feb; 17(2):2099-2106. PubMed ID: 30675277
[TBL] [Abstract][Full Text] [Related]
2. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
3. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
[TBL] [Abstract][Full Text] [Related]
4. [Clinical application of telomerase RNA component gene amplification assay in cervical lesions.].
Jiang J; Wei LH; Wu RF; Zhang G; Wulan N; Li JR; Li YB; Tu Z; Zhou YQ; Zhao Y; Chen Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):883-6. PubMed ID: 20193412
[TBL] [Abstract][Full Text] [Related]
5. Human telomerase RNA gene amplification detection increases the specificity of cervical intraepithelial neoplasia screening.
Zheng L; Liu AL; Qi T; Wang Q; Cai Z; Su YJ; Hu YW; Liu GB; Wei LH
Int J Gynecol Cancer; 2010 Aug; 20(6):912-7. PubMed ID: 20683395
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening.
Liang H; Fu M; Zhou J; Song L
Oncol Lett; 2016 Aug; 12(2):887-892. PubMed ID: 27446364
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas.
Kuglik P; Kasikova K; Smetana J; Vallova V; Lastuvkova A; Moukova L; Cvanova M; Brozova L
Neoplasma; 2015; 62(1):130-9. PubMed ID: 25563377
[TBL] [Abstract][Full Text] [Related]
8. [Value assessment of high-risk HPV test and TCT in the screening of cervical carcinoma].
Sun XF; Gu YQ; Wang AC; Wang J; Xie JL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):273-6. PubMed ID: 24579473
[TBL] [Abstract][Full Text] [Related]
9. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization testing for the diagnosis of high-grade cervical abnormalities: a systematic review.
Earley A; Lamont JL; Dahabreh IJ; Cowan J; Feldman S; Uhlig K
J Low Genit Tract Dis; 2014 Jul; 18(3):218-27. PubMed ID: 24477173
[TBL] [Abstract][Full Text] [Related]
11. Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.
Jiang J; Wei LH; Li YL; Wu RF; Xie X; Feng YJ; Zhang G; Zhao C; Zhao Y; Chen Z
J Mol Diagn; 2010 Nov; 12(6):808-17. PubMed ID: 20864639
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women.
Zhang R; Shi TY; Ren Y; Lu H; Wei ZH; Hou WJ; Zhang M; Xu C
J Clin Virol; 2013 Sep; 58(1):144-8. PubMed ID: 23849649
[TBL] [Abstract][Full Text] [Related]
13. Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders.
Tu Z; Zhang A; Wu R; Jiang J; Li Y; Wulan N; Li J; Zhang Y; Li Y; Chen Z; Wei L
Cancer Genet Cytogenet; 2009 May; 191(1):10-6. PubMed ID: 19389503
[TBL] [Abstract][Full Text] [Related]
14. Detection of hTERC and c-MYC genes in cervical epithelial exfoliated cells for cervical cancer screening.
Li T; Tang L; Bian D; Jia Y; Huang X; Zhang X
Int J Mol Med; 2014 May; 33(5):1289-97. PubMed ID: 24626956
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening.
You W; Li S; Du R; Zheng J; Shen A
Exp Ther Med; 2018 Jan; 15(1):412-418. PubMed ID: 29375696
[TBL] [Abstract][Full Text] [Related]
16. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
17. An efficient method that combines the ThinPrep cytologic test with E6/E7 mRNA testing for cervical cancer screening.
Pan D; Zhang CQ; Liang QL; Hong XC
Cancer Manag Res; 2019; 11():4773-4780. PubMed ID: 31213899
[No Abstract] [Full Text] [Related]
18. E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population.
Shi WJ; Liu H; Wu D; Tang ZH; Shen YC; Guo L
Oncol Lett; 2017 Nov; 14(5):6251-6258. PubMed ID: 29113275
[TBL] [Abstract][Full Text] [Related]
19. High-risk human papilloma virus infection and cervical neoplasm in female inflammatory bowel disease patients: a cross-sectional study.
Li M; Yang QF; Cao Q; Tang J; Gao Y; Zhi M; Chao K; Su ML; Huang WM; Yi Y; Xia SY; Huang LJ; Zhao Y; Wang XH; Liu XY; Lin L; Hu PJ; Gao X
Gastroenterol Rep (Oxf); 2019 Oct; 7(5):338-344. PubMed ID: 31687153
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
